APP and Alzheimer disease: In preclinical studies for AD drugs, APP transgenic mice are used as preclinical study models to evaluate drugs such as BACE1 and aducanumab monoclonal antibodies, etc (Kastanenka et al., 2016; Neumann et al., 2018).